Tex Heart Inst J. 2006; 33(1): 35–39.
Effect of Myocardial Reperfusion on the Release of
Nitric Oxide after Regional Ischemia
An Experimental Model of Beating-Heart
Surgery
Koki Nakamura, MD, Sharif Al-Ruzzeh, PhD, FRCS,
Caroline Gray, PhD, Magdi Yacoub, FRCS, and Mohamed Amrani, PhD, FRCS
The National Heart and Lung Institute, Imperial College
of Science, Technology and Medicine, University of London, Harefield
Hospital, Middlesex, United Kingdom
|
|
Abstract
Off-pump coronary artery bypass surgery is increasing in popularity
worldwide. However, very little is known about the effect of regional
myocardial ischemia-reperfusion on nitric oxide release.
In an animal model mimicking off-pump bypass, male Sprague-Dawley rats
(350 --450 g) were mechanically ventilated under general anesthesia. After
left lateral thoracotomy, the animals underwent occlusion of either the
left anterior descending artery (for 3, 5, 7.5, 10, 12.5, 15, or 20
minutes) or the circumflex artery (for 5, 10, or 15 minutes). Twenty-four
hours after reperfusion, heart tissue was stained for determination of the
area at risk and the infarcted area. Blood samples obtained before
ischemia, 10 minutes after reperfusion, and 24 hours after reperfusion
were analyzed for plasma concentrations of nitric oxide.
After occlusion of the left anterior descending artery, the size of the
infarcted area increased dramatically as the duration of occlusion
increased, and was significantly larger after 12.5, 15, or 20 minutes of
occlusion than after 3 minutes. After occlusion of the circumflex artery,
the size of the infarcted area increased steadily and was significantly
larger after 15 minutes of occlusion than after 5 minutes. There was no
significant correlation between the duration of coronary occlusion and the
plasma concentration of nitric oxide: 10 minutes after reperfusion, this
concentration was significantly lower than that before ischemia, but it
was twice the baseline level 24 hours after reperfusion. We concluded that
the duration of regional ischemia did not affect the plasma concentration
of nitric oxide in the systemic circulation.
Key words::
Animal
model, coronary artery bypass, off-pump, coronary artery occlusion,
temporary, myocardial ischemia, regional reversible, nitric oxide, rats,
Sprague-Dawley, reperfusion injury |
Since its revival during the past decade, off-pump coronary artery
bypass surgery (OPCAB) has been increasing in popularity
worldwide.1 Growing evidence regarding the hazards of using
cardiopulmonary bypass (CPB) for multivessel coronary artery bypass
grafting has prompted many cardiac surgeons in the United Kingdom to
convert to OPCAB.2 However, very little is known about the
correlation between nitric oxide (NO) release and regional ischemia
--reperfusion.
We and others3 --5 have shown that endothelial dysfunction
is common after ischemia --reperfusion injury and that postischemic
impairment of the endothelium results from a reduction in the release of
NO. Nitric oxide has numerous beneficial effects, including vasodilatory
properties, an inhibitory action on platelet aggregation, and antioxidant
effects.6 --12 Consequently, interventions aimed at reversing
the impairment of NO synthesis could have important implications for
cardiac function. However, the relationship between the ischemic period
and the release of NO has not been completely ascertained, nor has the
time course of NO release before and after ischemia --reperfusion.
Therefore, we performed this study to investigate the effect of temporary
coronary artery occlusion on the plasma concentration of NO and its
changes over time.
|
|
Materials
and Methods
Animals
Male Sprague-Dawley rats
(350 --450 g) were used in all experiments. In all studies, animals
received humane care in compliance with the "Principles of Laboratory
Animal Care" formulated by the National Society for Medical Research and
the "Guide for the Care and Use of Laboratory Animals" prepared by the
Institute of Laboratory Animal Resources and published by the National
Institutes of Health (NIH publication 85 --23, revised 1996).
Coronary Artery Occlusion
Rats were
anesthetized with 50 mg/kg of sodium pentobarbital administered
intraperitoneally. Rats underwent oral intubation with an 18-G soft venous
can-nula and artificial ventilation with room air. During the experiments,
the room temperature was maintained at 23 to 25[deg]C. In addition, a
heating pad was placed beneath the animals to maintain a body temperature
of 36.0 to 37.0[deg]C as determined by rectal temperature probe. A left
lateral thoracotomy was performed at the level of the 4th or 5th
intercostal space. The pericardium was opened, and the heart was exposed.
A 6-0 Prolene stitch was placed around the left anterior descending
coronary artery (LAD), 2 mm distal to the left atrial appendage and around
the circumflex artery (Cx), beneath the left atrial appendage along the
atrioventricular groove. A short length of polyethylene tubing was placed
over the suture as an occluder. The suture was tightened and clamped to
produce coronary occlusion and was released to produce reperfusion. The
LAD was occluded for 3, 5, 7.5, 10, 12.5, 15, or 20 minutes; the Cx was
occluded for 5, 10, or 15 minutes. Reperfusion followed. Approximately 10
minutes later, the chest was closed, and the rats were allowed to awake
spontaneously (1 -- 2 hours later). Control rats underwent thoracotomy
followed by closure of the chest without occlusion of a coronary
artery.
Myocardial Tissue
Analysis Twenty-four hours after reperfusion, the rats were again
anesthetized in the manner described above and were intubated via
tracheostomy. The chest was opened while the animals were artificially
ventilated with room air. The coronary artery was re-occluded with the
stitch that had been placed previously. The area at risk (AR) was stained
with Evans blue dye (2 mL of 2% w/v) injected via the femoral vein. (The
properties of Evans blue dye are such that the dye solution stains the
perfused myocardium, but the occluded nonperfused myocardium remains
uncolored.)
The heart was excised, the atrial and right ventricular walls were
removed, and the left ventricle (LV) was cut into 4 or 5 horizontal
slices. The AR, which included infarcted and ischemic myocardium, was
separated from the nonischemic myocardium by following the line of
demarcation between the blue-stained and the unstained (pink-to-red)
tissue. So that ischemic and infarcted tissue could be differentiated, the
AR was incubated in 0.1% nitro-blue tetrazolium (NBT) in a phosphate
buffer (pH 7.4) at 37[deg]C for 15 minutes. (The NBT dye forms a blue
formazan complex in the presence of coenzymes and dehydrogenases.) The
infarcted myocardium was then separated from the ischemic myocardium that
did not reach the degree of necrosis. The 3 portions of the LV myocardium
(nonischemic, ischemic, and infarcted) were weighed: AR was the sum of the
ischemic and infarcted areas (IF). The following percentages were
calculated and the results analyzed: the portion of the left ventricle
that was ischemic or infarcted (AR/LV), and the portion of AR that was
infarcted (IF/AR).
Analysis of the Plasma Concentrations of
Nitric Oxide The plasma concentrations of NO were analyzed using
0.6-mL blood samples collected before thoracotomy and ischemia, 10 minutes
after reperfusion, and 24 hours after reperfusion. The samples were
centrifuged, and the plasma was stored at [minus sign]70[deg]C until the
analyses were performed. Total NO production was determined with
chemiluminescence by an NO analyzer (NOA 270, Sievers Instruments, Inc.;
Boulder, Colo) to assay the amount of nitrite (the NO breakdown product)
that was present, as previously described.3 Levels of NO were
expressed in mol/L (M). Nitrite is measured as an index of total NO
production, because NO2[minus sign] is the principal
oxidation product in an aqueous solution devoid of any biological
contaminants.
Statistical Analysis
All values are
expressed as mean [plus minus] SEM. The 2 groups (LAD and Cx occlusion)
were compared by using Student's t-test after confirmation that
the data were normally distributed. Paired t-tests were used for
time-course studies of NO levels. The relationship between the plasma NO
level and the duration of coronary artery occlusion was analyzed by use of
Spearman's rank correlation test. For multiple comparisons, 1-way analysis
of variance (ANOVA) was performed, followed by Fisher's post hoc test to
determine which relationships were statistically significant. A
P-value of less than 0.05 was considered statistically
significant.
|
|
Results
Sixty-nine rats were used for the study: 40 in the LAD group, 25 in the
Cx group, and 4 as a control group (no occlusion). Forty-six rats (27 in
the LAD group, 16 in the Cx group, and 3 in the control group) survived
for 24 hours after reperfusion. The survival rate for the LAD group was
67.5%, and that for the Cx group was 64.0% (difference not statistically
significant). Among the surviving animals, staining failed in 6 rats, and
occlusion was not properly performed for 3 rats (as confirmed by
staining). Consequently, the final analysis included 37 rats: 23 in the
LAD group, 11 in the Cx group, and 3 in the control group.
Myocardial Ischemia Induced by Coronary
Artery Occlusion The AR weighed significantly more in the LAD group
(0.305 [plus minus] 0.014 g) than in the Cx group (0.206 [plus minus]
0.026 g; P <0.001). In addition, the AR/LV was 40.4% [plus
minus] 1.7% in the LAD group and 25.4% [plus minus] 2.9% in the Cx group
(P <0.0001). For the variable dura-tion of occlusion of the
LAD and the Cx, the AR/LV did not differ significantly. In the LAD group,
IF/AR dramatically increased in a time-dependent manner: 4.5% [plus minus]
3.2% after 3 min of occlusion; 9.7% [plus minus] 5.2% after 5 min; 17.2%
[plus minus] 3.0% after 7.5 min; 16.8% [plus minus] 2.7% after 10 min;
23.9% [plus minus] 9.5% after 12.5 min; 62.4% [plus minus] 2.9% after 15
min; and 63.4% [plus minus] 2.9% after 20 min (for statistical
significance of these results see Fig. 1). The IF/AR in the Cx group
increased steadily in a time-dependent manner: 14.3% [plus minus] 2.3%
after 5 min of occlusion; 25.9% [plus minus] 2.1% after 10 min; and 40.9%
[plus minus] 6.2% after 15 min (for statistical significance, see Fig. 2).
Plasma Nitric Oxide
Concentrations There was no statistically significant relationship
between the duration of coronary artery occlusion and the plasma
concentration of NO at any of the blood collection time points (Fig. 3).
However, significant changes in the plasma concentrations of NO were
observed in the time-course study: 26.9 [plus minus] 2.5 M before
ischemia, 21.6 [plus minus] 0.9 [mu]M at 10 minutes after reperfusion
(P <0.05 compared with pre-ischemia levels), and 48.6 [plus
minus] 3.6 [mu]M at 24 hours after reperfusion (P <0.0001
compared with pre-ischemia levels and those at 10 minutes after
reperfusion) (Fig. 4).
|
|
Discussion
We found no significant correlation between the duration of coronary
artery occlusion and the plasma concentration of NO. In the time-course
study, the plasma NO had decreased significantly at the beginning of
reperfusion but was twice the baseline level 24 hours after
reperfusion.
Endothelium-derived NO not only modulates the tone of the underlying
vascular smooth muscle but also inhibits several proatherogenic processes,
including smooth muscle proliferation and migration, platelet aggregation,
oxidation of low-density lipoproteins, monocyte and platelet adhesion, and
synthesis of inflammatory cytokines.12 Consequently,
interventions aimed at reversing impaired NO synthesis could have
important implications for cardiac function.
In the present study, reperfusion affected NO production independent of
the duration of coronary occlusion. Many studies have shown that an
important feature of ischemia --reperfusion injury is the postischemic
impairment of the endothelium, which is partially due to a reduction in NO
release.3 --5 Indeed, our study also showed that beginning the
reperfusion process decreased the plasma concentration of NO. The decrease
in NO production at 10 minutes after reperfusion was likely due to the
endothelial dysfunction caused by reperfusion.
A few reports have shown that the release of NO increases because of
the inflammatory response associated with the use of CPB in cardiac
surgery.13 --15 In those circumstances, the production of such
a large amount of NO might be inhibited by treating CPB patients with
glucocorticoids, aprotinin, and hemofiltration.13 On the other
hand, in human beings it has also been shown that, even during CPB, NO
production in the coronary sinus decreases significantly after grafting
with an internal thoracic artery.16
L-arginine, the physiologic substrate of NO, reverses low coronary
reflow and improves postischemic recovery of cardiac mechanical
function.3 Therefore, supplementation with L-arginine may be
effective in increasing NO production after coronary surgery
---particularly if OPCAB is used (avoiding CPB).
The increase in the NO concentrations detected 24 hours after
reperfusion in our study may have been related to the systemic
inflammatory reaction induced by the surgical procedures, or caused by an
alternative mechanism that counteracted the reduction in NO concentration.
Ferreiro and colleagues17 reported that hypoxia down-regulated
endothelial nitric oxide synthase (NOS) activity in the cardiac tissue of
cyanotic children; in contrast, inducible NOS activity was up-regulated as
a counteraction.
We speculate that, in our study, the plasma NO concentration was
independent of the degree of ischemia because of the change in NO release,
which may have been diluted in the systemic circulation. One study
limitation was that the blood samples were obtained from the femoral vein.
Obtaining samples from the coronary sinus would have better reflected the
changes in NO release in the heart. However, accessing the coronary sinus
in rats is technically difficult, and we considered that the change in NO
concentrations in the systemic circulation would indirectly reflect such
changes in the heart. Future studies in larger animals may allow
collection of blood samples from the coronary sinus so that minor changes
in NO concentrations in the heart can be investigated. Another limitation
of this study was that the rat heart model involved healthy coronary
arteries. Although this limitation would make any extrapolation difficult,
we believe that this model could assist in the investigation of several
aspects of regional ischemia in OPCAB.
In conclusion, the duration of regional ischemia did not affect the
plasma concentration of NO in the systemic circulation. This concentration
decreased at the beginning of reperfusion but was twice as high as
baseline 24 hours after reperfusion.
|
|
Footnotes
|
|
References
1.
Yacoub M. Off-pump coronary bypass surgery: in search
of an identity. Circulation 2001;104:1743 --5. [PubMed] [Free Full Text].
2.
Anyanwu AC, Al-Ruzzeh S, George SJ, Patel R, Yacoub MH,
Amrani M. Conversion to off-pump coronary bypass without increased
morbidity or change in practice. Ann Thorac Surg 2002;73:798 --802. [PubMed].
3.
Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub
MH. L-arginine reverses low coronary reflow and enhances postischemic
recovery of cardiac mechanical function. Cardiovasc Res 1995;30:200 --4.
[PubMed] [Full Text].
4.
Amrani M, Gray CC, Smolenski RT, Goodwin AT, London A,
Yacoub MH. The effect of L-arginine on myocardial recovery after
cardioplegic arrest and ischemia under moderate and deep hypothermia.
Circulation 1997;96(9 Suppl):II-274 --9.
5.
Pernow J, Uriuda Y, Wang QD, Li XS, Nordlander R,
Rydeen L. The protective effect of L-arginine on myocardial injury and
endothelial function following ischaemia and reperfusion in the pig. Eur
Heart J 1994;15:1712 --9. [PubMed].
6.
Spooner TH, Dyrud PE, Monson BK, Dixon GE, Robinson LD.
Coronary artery bypass on the beating heart with the Octopus: a North
American experience. Ann Thorac Surg 1998;66:1032 --5. [PubMed] [Full Text].
7.
Akins CW, Boucher CA, Pohost GM. Preservation of
interventricular septal function in patients having coronary artery bypass
grafts without cardiopulmonary bypass. Am Heart J 1984;107:304 --9. [PubMed].
8.
Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar
LF, Gomes WJ. Coronary artery bypass grafting without cardiopulmonary
bypass. Ann Thorac Surg 1996;61:63 --6. [PubMed] [Full Text].
9.
Mills SA. Cerebral injury and cardiac operations. Ann
Thorac Surg 1993;56(5 Suppl):S86 --91. [PubMed].
10.
Gundry SR, Romano MA, Shattuck OH, Razzouk AJ, Bailey
LL. Seven-year follow-up of coronary artery bypasses performed with and
without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;115:1273
--8. [PubMed] [Full Text].
11.
Brown PM Jr, Kim VB, Boyer BJ, Lust RM, Chitwood WR Jr,
Elbeery JR. Regional left ventricular systolic function in humans during
off-pump coronary bypass surgery. Circulation 1999;100(19 Suppl):II125
--7. [PubMed] [Free Full Text].
12.
Shimokawa H. Primary endothelial dysfunction:
atherosclerosis. J Mol Cell Cardiol 1999;31:23 --37. [PubMed] [Full Text].
13.
Hill GE. Cardiopulmonary bypass-induced inflammation:
is it important? J Cardiothorac Vasc Anesth 1998;12(2 Suppl 1):21 --5.
[PubMed].
14.
Hiramatsu T, Imai Y, Takanashi Y, Hoshino S, Yashima M,
Tanaka SA, et al. Time course of endothelin-1 and nitrate an-ion levels
after cardiopulmonary bypass in congenital heart defects. Ann Thorac Surg
1997;63:648 --52. [PubMed] [Full Text].
15.
Ruvolo G, Speziale G, Greco E, Tritapepe L, Mollace V,
Nistico G, Marino B. Nitric oxide release during hypothermic versus
normothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1995;9:651
--4. [PubMed].
16.
Tarr FI, Sasvari M, Dudas G, Kroo M, Somogyi A,
Tomcsanyi I. Quantitative measurement of endothelium derived nitric oxide
production of the internal mammary artery bypass graft during
extracorporeal circulation. Eur J Cardiothorac Surg 2001;19:653 --6. [PubMed] [Full Text].
17.
Ferreiro CR, Chagas AC, Carvalho MH, Dantas AP, Jatene
MB, Bento De Souza LC, Lemos Da Luz P. Influence of hypoxia on nitric
oxide synthase activity and gene expression in children with congenital
heart disease: a novel pathophysiological adaptive mechanism. Circulation
2001;103: 2272 --6. [PubMed]
[Free Full
Text]. |
|
Figures and
Tables
 |
Fig. 1 The IF/AR in the
LAD occlusion group. |
 |
Fig. 2 The IF/AR in the
Cx occlusion group. |
 |
Fig. 3 Correlation
between the duration of coronary artery occlusion and the plasma
concentration of nitric oxide (NO): A) before
ischemia, B) 10 minutes after reperfusion, and
C) 24 hours after reperfusion. There was no
statistically significant correlation (more
...) |
 |
Fig. 4 Time course of the
plasma concentration of nitric oxide (NO). Samples from the control
rats were not included. | |
|